​a Prof. Corp. 

speaking engagements


●  "Claim Construction and Proving Infringement: The Impact of Phillips, Festo and their Progeny" Practising Law Institute, September 2008
●  "Research Tool Patents in Legal Limbo: The Last Chapter in Integra v. Merck" IP Law and Business, September 2007
●  "Patent Misuse in the Pharmaceutical Industry: Developments in US & EU" Pharmaceutical Law Insight, February 2007
●  "Biotech Roundtable: Proposed Legislation and New PTO Rules Affecting Life Science Companies" (Panel Discussion and Article) IP Law and Business, August 2006
●  Nuts and Bolts of IP Due Diligence Continuing Education of the Bar, January 2006
●  Intellectual Property Due Diligence in Connection with Investment, Acquisition, or Collaboration in a Technology-Based Entity State Bar of California Intellectual Property Section, January 2006
●  Enablement and Written Description as Applied to Biotechnology Cases Practising Law Institute, September 2005

​


●  "Orange Book Listings, De-Listings and Related Challenges," American Conference Institute – Hatch-Waxman Boot Camp, July 2011
●  "An Overview of the Statutory Dispute Resolution Mechanisms: Steering Clear of Any Potential Gaps in the Litigation," American Conference Institute 2nd Annual Conference on Biosimilars, June 2011
●  "Exploring Exclusivity and Forfeiture Dilemmas Relative to Paragraph IV Litigation," American Conference Institute - Paragraph IV Disputes, December 2010
●  "Biosimilars Legislation and Patent Litigation: Developing New Procedures and Strategies," Stanford Law School, November 2010
●  "Orange Book Listings, De-Listings and Related Challenges," American Conference Institute – Hatch-Waxman Boot Camp, May 2010
●  "Ethics Issues That Arise When Protecting Intellectual Property," Practicing Law Institute – Common Ethics Issues in IP Transactions, February 2010
​●  "Drug Exclusivity Strategies: Protecting and Optimizing Your Pharmaceutical Assets," March 2009
●  Trade Secret Disputes - Navigating Muddy Waters," Association of Corporate Counsel, Life Sciences Roundtable, June 2009
●  "Claims Construction and Proving Infringement," Practicing Law Institute: Patent Litigation, September 2008

​​​●  "Generic Biopharmaceuticals: Current Landscape and Future Perspectives," Licensing Executives Society, May 2008

●  "Follow-On (Comparable or Biosimilar) Biologics," ACI's FDA Bootcamp, May 2008

●  "Biogenerics or Biosimilars,: Licensing Executives Society, San Diego, May 2008
●  "The Federal Circuit's Ruling in Festo XIII: Doctrine of Equivalents Further Eroded," Practising Law Institute, September 2007
●  "Developments in Enablement, Written Description and Non-Obviousness Requirements in Biotechnology," Practising Law Institute, June 2007
●  "Safe Harbor Update: The Scope of the Research Exemption Post-Integra," American Conference Institute, June 2007
●  "Developments in Enablement and Written Description Requirements as Applied to Biotechnology Cases," Practising Law Institute, September 2006
●  "Merck KGaA v. Integra: New Options for Biotechs?" September 2006
●  "Polymorph Patents: The Shape of Things," GPhA Annual Policy Conference, September 2006
●  "ALM Biotech Roundtable: Proposed Legislation and New PTO Rules Affecting Life Science Companies" (Panel Discussion and Article), August 2006
●  "180-Day Exclusivity," American Conferencing Institute, June 2006
●  "Angel Investor Forum: Panel on IP Due Diligence," February 2006
●  "Licensing Strategies after Merck v. Integra" Licensing Executives Society, February 2006

publications

jessica r. wolff, esq.
REGISTERED PATENT attorney

Wolff IP

  • ●  "Satisfying the Written Description Requirement in Biotech Cases" IP Wire, November 2004
  • ●  "The Rise of Generic And ‘Branded Generics' Cause Dramatic Increase in Pharmaceutical Patent Litigation" Intellectual Property Today, Vol. 11, No. 1, p. 18, January 2004
  • ●  "Rise of Generic Drugs Drives Up Volume, Intensity of Patent Litigation" San Diego Daily Transcript, May 2003
  • ●  "Generic Drug Wars--Big Business Spawns Big Patent Litigation" The Patent Journal, Vol. 1, No. 7, p.1, April 2002
  • ●  Patent Protection Impact San Diego Daily Transcript, June 21, 1995
  • ●  "Patent Appeals Court Addresses Obviousness and Enablement/Utility in Biotech Cases" San Diego Daily Transcript, June 21, 1995
  • ●  "Intellectually Speaking" San Diego Daily Transcript, December 17, 1993